These include skin rash or hives, weak muscles or cramps, itching, vomiting, nausea, headache, leg pain or warm, tender pain in one leg, dizziness and fatigue, frequent urination, feeling super thirsty, fast heart rate, and swelling of the extremities
[5] [6] By mimicking and prolonging these effects, cagrilintide helps reduce caloric intake and supports weight loss
Tendon Research Its no surprise that BPC-157 has shown promise in treating ligament, tendon, bone, and other connective tissue injuries in animal models
BPC-157 steht seit 2022 auf der WADA-Verbotsliste in der Kategorie S0 (Non-Approved Substances) Wettkampfsportler in WADA-berwachten Disziplinen riskieren mehrjhrige Sperren ohne Mglichkeit zur Therapeutic Use Exemption